Nov. 12, 2013
This chip based system incorporates microfluidics with label free optical detection. It can be used to replace ELISA based detection schemes for point of care detection of infectious diseases, cancer, and other diseases detected using antibodies or alternative chemical recognition means. The technology has been demonstrated in Dengue fever detection and work is ongoing in Leukemia detection.
Description:
This microfluidic chip based detection system takes antibody or other ligand binding detection to a robust low cost platform based on long-range surface plasmon polariton (LRSPP) waveguides that are easily built into the microfluidic chips. The LRSPPs are monitored to detect ligand binding without the use of labels. Our first tests detect IgM specific to the Dengue Fever virus in patient blood plasma samples. It provides the following benefits.由于技术保密工作限制，技术信息无法完全展现，请通过邮箱或短信联系我们，获取更多技术资料。
detect ligand binding
dengue fever virus
dengue fever detection
ligand binding detection
B5, No.1600, North Guoquan Rd, Yangpu, Shanghai
info@yintrust.com
021-65679356
Premium